Business Today TheFoxPosts.com

Crumbling COVID-19 vaccine and treatment sales chopped Pfizer’s second-quarter earnings, but both the drugmaker and Wall Street expect a rebound in the back half of 2023 Crumbling COVID-19 vaccine and treatment sales chopped Pfizer’s second-quarter earnings, but both the drugmaker and Wall Street expect a rebound in the back half of 2023. Pfizer recorded no U.S. sales of its treatment, Paxlovid, in the recently completed quarter, as the company shifts to selling the pills on the commercial market after contracting with the government. Paxlovid brought in only $143 million total sales during the quarter after recording $8 billion in last year’s quarter. Sales of the vaccine Comirnaty also slid 83% to $1.49 billion in the quarter, as both products fell short of Wall Street expectations. Both Pfizer’s leaders and analysts who follow the company had expected a sales drop in the quarter as inventories already on the market were used up. But they also expect a rebound later this year, as ...

Americans 60 and older can get a new RSV vaccine but should discuss it with their doctor first Americans 60 and older can get a new RSV vaccine but should discuss it with their doctor first, U.S. Health officials recommended Thursday. The newly approved vaccines are expected to be ready in the fall, a time when flu shots and updated COVID-19 shots also will be available. Those eligible for the RSV vaccine should talk with their doctor to see if it is right for them, the Centers for Disease Control and Prevention said in a statement. The CDC said adults with chronic heart or lung disease, weakened immune systems and those living in long-term care facilities are at higher risk for the respiratory infection. RSV, or respiratory syncytial virus, is a common cause of cold-like symptoms but it can be dangerous for infants and the elderly. A surge last year filled hospitals with wheezing children. There's no vaccine yet for kids, but one for pregnant women to prevent illness in infant...

The Florida Supreme Court will convene a grand jury at Republican Gov. Ron DeSantis' request to investigate any wrongdoing with respect to the COVID-19 vaccines TALLAHASSEE -- The Florida Supreme Court will convene a grand jury at Republican Gov. Ron DeSantis’ request to investigate any wrongdoing with respect to the COVID-19 vaccine s, the court announced Thursday. The Republican governor, who is often mentioned as a possible presidential candidate in 2024, earlier this month called for the investigation. He suggested it would be in part aimed to jog loose more information from pharmaceutical companies about the vaccine s and potential side effects. Vaccine studies funded by pharmaceutical companies that developed COVID-19 vaccine s have been published in peer-reviewed journals such as the New England Journal of Medicine, and government panels reviewed data on the safety and effectiveness of the shots before approving them for use. DeSantis' request argues that phar...